An Assessment of a Rapid SARS-CoV-2 Antigen Test in Bangladesh.


Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
12 10 2022
Historique:
received: 23 01 2022
accepted: 21 04 2021
pubmed: 16 8 2022
medline: 19 10 2022
entrez: 15 8 2022
Statut: epublish

Résumé

Early detection of SARS-CoV-2 infection is crucial to prevent its spread. This study aimed to document test sensitivity/specificity, correlation with cycle threshold value from polymerase chain reaction (PCR), fitness-for-use in different populations and settings, and user perspectives that could inform large-scale implementation. In this study, we evaluated the performance of a rapid antigen detection test, BD Veritor, and compared this (and another rapid test, Standard Q) against reverse transcription PCR (RT-PCR) in terms of sensitivity and specificity in 130 symptomatic and 130 asymptomatic adults. In addition, we evaluated the suitability and ease of use of the BD Veritor test in a subsample of study participants (n = 42) and implementers (n = 5). At 95% confidence interval, the sensitivity of the BD Veritor and Standard Q test were 70% and 63% in symptomatic and 87% and 73% in asymptomatic individuals, respectively, regarding positive SARS-CoV-2 RT-PCR results. Overall, the BD Veritor test was 78% sensitive and 99.5% specific compared with RT-PCR irrespective of the cycle threshold. This warrants large field evaluation as well as use of the rapid antigen test for quick assessment of SARS-CoV-2 for containment of epidemics in the country.

Identifiants

pubmed: 35970285
doi: 10.4269/ajtmh.22-0068
pii: tpmd220068
pmc: PMC9651516
doi:

Substances chimiques

Antigens, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

845-849

Références

Lancet Microbe. 2021 May;2(5):e219-e224
pubmed: 33748803
JAMA Netw Open. 2021 May 3;4(5):e2110071
pubmed: 33988707
ACS Infect Dis. 2020 Sep 11;6(9):2513-2523
pubmed: 32786273
Afr J Lab Med. 2020 Sep 30;9(1):1255
pubmed: 33102170
Virol J. 2021 Feb 13;18(1):34
pubmed: 33581714
Phlebology. 2012 Aug;27(5):250-1
pubmed: 22956651
Virol J. 2020 Nov 13;17(1):177
pubmed: 33187528
Int J Gen Med. 2021 Feb 12;14:435-440
pubmed: 33603450
BMC Med. 2021 Apr 14;19(1):94
pubmed: 33849546
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32404480
ACS Nano. 2020 Apr 28;14(4):3822-3835
pubmed: 32223179

Auteurs

Zannat Kawser (Z)

Institute for Developing Science and Health Initiatives (ideSHi), Dhaka, Bangladesh.

Mohabbat Hossain (M)

Institute for Developing Science and Health Initiatives (ideSHi), Dhaka, Bangladesh.

Sara Suliman (S)

Division of Experimental Medicine, Zuckerberg San Francisco General Hospital, San Francisco, California.

Shahin Lockman (S)

Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts.
Harvard T.H. Chan School of Public Health, Boston, Massachusetts.

Jesse Gitaka (J)

Directorate of Research and Innovation, Mount Kenya University, Thika, Kenya.
Centre for Malaria Elimination, Mount Kenya University, Thika, Kenya.

Gama Bandawe (G)

Biological Sciences Department, Academy of Medical Sciences, Malawi University of Science and Technology, Thyolo, Malawi.

Redwan Rahmat (R)

Institute for Developing Science and Health Initiatives (ideSHi), Dhaka, Bangladesh.

Imrul Hasan (I)

Institute for Developing Science and Health Initiatives (ideSHi), Dhaka, Bangladesh.

Abu Bakar Siddik (AB)

Institute for Developing Science and Health Initiatives (ideSHi), Dhaka, Bangladesh.

Mokibul Hassan Afrad (MH)

International Center for Diarrheal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.

Mohammed Ziaur Rahman (MZ)

International Center for Diarrheal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.

Glenn Miller (G)

Mass General Brigham Center for COVID Innovation, Boston, Massachusetts.

David R Walt (DR)

Mass General Brigham Center for COVID Innovation, Boston, Massachusetts.
Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, Massachusetts.
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Louise C Ivers (LC)

Department of Global Health and Social Medicine, Harvard Medical School, Boston Massachusetts.
MGH Center for Global Health, Massachusetts General Hospital, Boston, Massachusetts.

Regina C LaRocque (RC)

MGH Center for Global Health, Massachusetts General Hospital, Boston, Massachusetts.

Jason B Harris (JB)

MGH Center for Global Health, Massachusetts General Hospital, Boston, Massachusetts.

Firdausi Qadri (F)

International Center for Diarrheal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH